1. EP1118 Patient-derived ovarian cancer organoids resemble clinical response to chemotherapeutics and provide insights into response mechanisms. (1st November 2019) Authors: de Witte, CJ; Stelloo, E; Hami, N; Espejo Valle-Inclan, J; Lõhmussaar, K; Kopper, O; Vreuls, C; Jonges, T; van Diest, PJ; Clevers, H; Snippert, HJG; Kloosterman, WP; Zweemer, RP; Witteveen, PO Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP828 Whole genome sequencing and clinical drug response data of 142 ovarian cancer samples. (1st November 2019) Authors: de Witte, CJ; Kutzera, J; Espejo Valle-Inclan, J; van Roosmalen, MJ; Boymans, S; Cuppen, E; Kloosterman, WP; Zweemer, RP; Witteveen, PO Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P119 An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. (1st November 2019) Authors: Kopper, O; de Witte, CJ; Lõhmussaar, K; Espejo Valle-Inclan, J; Hami, N; Kester, L; Balgobind, AV; Korving, J; Proost, N; Begthel, H; van Wijk, LM; Revilla, SA; Theeuwsen, R; van de Ven, M; van Roosmalen, MJ; Ponsioen, B; Ho, VWH; Neel, BG; Bosse, T; Gaarenstroom, KN Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗